Annual ROE
-51.91%
-8.97%-20.89%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual return on equity is -51.91%, with the most recent change of -8.97% (-20.89%) on December 31, 2023.
- During the last 3 years, ANTX annual ROE has fallen by -118.86% (-177.54%).
- ANTX annual ROE is now -177.54% below its all-time high of 66.95%, reached on December 31, 2020.
Performance
ANTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-57.63%
-2.91%-5.32%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly return on equity is -57.63%, with the most recent change of -2.91% (-5.32%) on September 30, 2024.
- Over the past year, ANTX quarterly ROE has dropped by -0.47% (-0.82%).
- ANTX quarterly ROE is now -88.21% below its all-time high of -30.62%, reached on March 31, 2022.
Performance
ANTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ANTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | -0.8% |
| 3 y3 years | -177.5% | -0.8% |
| 5 y5 years | -177.5% | -0.8% |
ANTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.2% | at low | -88.2% | +3.4% |
| 5 y | 5-year | -177.5% | at low | -88.2% | +3.4% |
| alltime | all time | -177.5% | at low | -88.2% | +3.4% |
AN2 Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -57.63%(+5.3%) |
| Jun 2024 | - | -54.72%(-4.3%) |
| Mar 2024 | - | -57.16%(-4.2%) |
| Dec 2023 | -51.91%(+20.9%) | -59.67%(+1.2%) |
| Sep 2023 | - | -58.99%(+0.8%) |
| Jun 2023 | - | -58.52%(+20.1%) |
| Mar 2023 | - | -48.71%(+28.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -42.94%(+23.4%) | -37.90%(+3.1%) |
| Sep 2022 | - | -36.77%(+11.4%) |
| Jun 2022 | - | -33.01%(+7.8%) |
| Mar 2022 | - | -30.62%(-12.0%) |
| Dec 2021 | -34.80%(-152.0%) | - |
| Dec 2021 | - | -34.80% |
| Dec 2020 | 66.95% | - |
FAQ
- What is AN2 Therapeutics annual return on equity?
- What is the all time high annual ROE for AN2 Therapeutics?
- What is AN2 Therapeutics annual ROE year-on-year change?
- What is AN2 Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly ROE year-on-year change?
What is AN2 Therapeutics annual return on equity?
The current annual ROE of ANTX is -51.91%
What is the all time high annual ROE for AN2 Therapeutics?
AN2 Therapeutics all-time high annual return on equity is 66.95%
What is AN2 Therapeutics annual ROE year-on-year change?
Over the past year, ANTX annual return on equity has changed by -8.97% (-20.89%)
What is AN2 Therapeutics quarterly return on equity?
The current quarterly ROE of ANTX is -57.63%
What is the all time high quarterly ROE for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly return on equity is -30.62%
What is AN2 Therapeutics quarterly ROE year-on-year change?
Over the past year, ANTX quarterly return on equity has changed by -0.47% (-0.82%)